Wells Fargo & Company Issues Positive Forecast for Axsome Therapeutics (NASDAQ:AXSM) Stock Price
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price target raised by equities research analysts at Wells Fargo & Company from $140.00 to $160.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target would indicate a potential upside of 21.51% […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price target raised by equities research analysts at Wells Fargo & Company from $140.00 to $160.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target would indicate a potential upside of 21.51% […]